https://orcid.org/0000-0002-4494-0665
References
- Baer RJ, Norton ME, Shaw GM, et al. Risk of selected structural abnormalities in infants after increased nuchal translucency measurement. Am J Obstet Gynecol. 2014;211(6):675.e1–675.19.
- Hellmuth SG, Pedersen LH, Miltoft CB, et al. Increased nuchal translucency thickness and risk of neurodevelopmental disorders. Ultrasound Obstet Gynecol. 2017;49(5):592–598.
- Grande M, Jansen FAR, Blumenfeld YJ, et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;46(6):650–658.
- Kearney HM, Thorland EC, Brown KK, et al., Working Group of the American College of Medical Genetics Laboratory Quality Assurance. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680–685.
- Cicero S, Sacchini C, Rembouskos G, et al. Sonographic markers of fetal aneuploidy–a review. Placenta. 2003;24:S88–S98.
- Souka AP, Von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 2005;192(4):1005–1021.
- Scott F, Murphy K, Carey L, et al. Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: results from over 1000 consecutive cases. Ultrasound Obstet Gynecol. 2013;41(5):500–507.
- Huang J, Poon LC, Akolekar R, et al. Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH? Ultrasound Obstet Gynecol. 2014;43(6):620–624.
- Oneda B, Rauch A. Microarrays in prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol. 2017;42:53–63.
- Lund IC, Christensen R, Petersen OB, et al. Chromosomal microarray in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 2015;45(1):95–100.
- Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184.
- Goldenberg P. An update on common chromosome microdeletion and microduplication syndromes. Pediatr Ann. 2018;47(5):e198–e203.
- Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;41(6):610–620.
- Yatsenko SA, Davis S, Hendrix NW, et al. Application of chromosomal microarray in the evaluation of abnormal prenatal findings. Clin Genet. 2013;84(1):47–54.
- Oneda B, Baldinger R, Reissmann R, et al. High-resolution chromosomal microarrays in prenatal diagnosis significantly increase diagnostic power. Prenat Diagn. 2014;34(6):525–533.
- Yang X, Li R, Fu F, et al. Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype. J Matern Fetal Neonatal Med. 2017;30(2):194–198.
- Bornstein E, Berger S, Cheung SW, et al. Universal prenatal chromosomal MicroarrayAnalysis: additive value and clinical Dilemmasin fetuses with a normal karyotype. Am J Perinatol. 2017;34(4):340–348.
- Maya I, Yacobson S, Kahana S, et al. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis. Ultrasound Obstet Gynecol. 2017;50(3):332–335.
- Huang L-Y, Pan M, Han J, et al. What would be missed in the first trimester if nuchal translucency measurementis replaced by cell free DNA foetal aneuploidy screening? J Obstet Gynaecol. 2018;38(4):498–501.